Holiferm

Manchester, United Kingdom Founded: 2018 • Age: 8 yrs
Manufacturer of biosurfactants

About Holiferm

Holiferm is a company based in Manchester (United Kingdom) founded in 2018 by Ben Dolman. Holiferm has raised $25.73 million across 4 funding rounds from investors including Greater Manchester Combined Authority, Rhapsody Venture Partners and Clean Growth Fund. The company has 29 employees. Holiferm offers products and services including Sophorolipid Products, GranuSurf, and LF Biosurfactants. Holiferm operates in a competitive market with competitors including Dispersa, Sironix, Ruby Bio, Lipofabrik and AGAE Technologies, among others.

  • Headquarter Manchester, United Kingdom
  • Employees 29
  • Founders Ben Dolman
  • Sectors
    Chemicals & Materials
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website holiferm.com
  • Social LinkedIn Instagram
  • Legal Name Holiferm Limited
Key Metrics

Products & Services of Holiferm

Holiferm offers a comprehensive portfolio of products and services, including Sophorolipid Products, GranuSurf, and LF Biosurfactants.

Sophorolipid Products
Biosurfactants

Range of biosurfactants for industrial and consumer applications using fermentation.

GranuSurf
Surfactant

Granulated biosurfactant for enhanced product formulations and eco-friendly uses.

LF Biosurfactants
Biosurfactants

Sustainable surfactants designed for various global market applications.

Funding Insights of Holiferm

Holiferm has successfully raised a total of $25.73M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $23.15 million completed in December 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $25.73M
  • Total Rounds 4
  • Last Round Series B β€” $23.15M
  • First Round $474,914

    (Nov 2020)

  • Investors Count 4

All 4 funding rounds of Holiferm with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Dec 2023$23.15MSeries B–Rhapsody Venture Partners, Clean Growth Fund
–
Jul 2023$2.58MSeed–Greater Manchester Combined Authority
–
Nov 2021–Seed–Clean Growth Fund, Rhapsody Venture Partners
–
Nov 2020$474,914Grant––
–
Valuation history

4 investors in total: 4 institutional.

Investors in Holiferm

Holiferm has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Greater Manchester Combined Authority, Rhapsody Venture Partners and Clean Growth Fund.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Early-stage tech & life sciences focused VC firm investing in geographies such as the US
–rhapsodyvp.comCambridge, United States
Early-stage cleantech entrepreneurs are supported with expert capital.
–cleangrowthfund.comUnited Kingdom
Icos Capital is focused on sustainability through technology investments.
–icoscapital.comAmsterdam, Netherlands
Government programs and development services are delivered in Greater Manchester.
2011greatermanchester-ca.gov.ukManchester, United Kingdom
Premium access

Investor details for Holiferm

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Holiferm

34 people are tracked at Holiferm (10 in leadership, 24 in team); the tracked headcount is 29.

NameRoleGroup
Ben Dolman
Founder & CIOLeadership
Charles Dimmler
CEOLeadership
Alice Robinson
Operations DirectorLeadership
Beth Foster
Financial DirectorLeadership
Peter Van Gelderen
Investor DirectorLeadership
Clare Walker
Head Of Global Regulations And Product SafetyLeadership
James Winterburn
Technical DirectorLeadership
Richard Lock
Chief Operating OfficerLeadership
Vicky De Groof
Chief Technical OfficerLeadership
Jason Whaley
Investor DirectorLeadership
Ewa Fic
Plant OperatorTeam
Andrew Hardwick
Marketing And Business Support ManagerTeam
Dave Atherton
Quality ManagerTeam
Matthew Wharton
OperatorTeam
Tom Sirrett
OperatorTeam
Danail Milev
Scale Up & Manufacturing EngineerTeam
Joana Pereira
Commercial ManagerTeam
Ismaeel Khan
Sales ManagerTeam
Lewis Wright
Assistant AccoutantTeam
Benjamin Reed
Sr. Sales Manager, AmericasTeam

14 more people are available in the full profile.

Premium access

Complete people profiles for Holiferm

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Holiferm

3 dated milestones of Holiferm across 5 years, from founding to its latest funding, stage changes and deals.

  1. Founded Holiferm is founded.
  2. Funding First funding round of $475K.
  3. Funding Latest funding round, Series B, of $23.1M.

Competitors of Holiferm

Holiferm operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Dispersa, Sironix, Ruby Bio, Lipofabrik and AGAE Technologies, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
dispersa.ca2018Laval, Canada$6.29M–
Biosurfactants are developed using microbes for cleaning and personal care.
sironixrenewables.com2016Seattle, United States$5.77M–
Manufacturer of plant-based surfactants
rubybio.com2020San Carlos, United States$13.12M–
Provider of naturally occurring yeast services for food & beverage and personal & healthcare industry
lipofabrik.com2013–––
Manufactures bacillus species-based lipopeptides
agaetech.com2011Corvallis, United States$1.1M–
Biosurfactant products are supplied for pharmaceutical and cosmeceutical applications.
jeneilbiotech.com1995Saukville, United States–100
Manufactures natural dairy flavors, probiotics, and biosurfactants using fermentation technology.
emulseo.com2018Pessac, France––
Develops innovative surfactant technologies for biotechnological uses.
teegene.co.uk2014Redcar, United Kingdom––
Biotechnology firm produces natural biosurfactants for oil, agriculture, and cosmetics sectors.
nds-ecosolutions.co.uk2020Hawarden, United Kingdom–2
Eco-friendly industrial cleaners for ultrasonics, parts washing, and wind turbines.
Premium access

Detailed competitors of Holiferm

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Holiferm

The website of Holiferm (holiferm.com) receives about 3.6K visits a month.

  • Monthly visits
    3.6K

    ▼ 1.1% vs previous month

Latest news on Holiferm

Premium access

Complete news archive for Holiferm

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Holiferm

10 companies that operate in the same segment as Holiferm (Chemicals Tech), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Microbe-based plant protection products and yield optimization services are provided.
2013Boston, Massachusetts, United StatesUSD 1.4 B––
Plant-based biopesticides are developed for agricultural applications by Terramera.
2010Vancouver, British Columbia, CanadaUSD 64.94 MUSD 3.42 M16
Conductive nanocoatings are delivered via atomic layer deposition technology.
2013Boulder, Colorado, United StatesUSD 202.75 M––
Developr of bio-based products and natural compounds for biotechnological solutions
1993Zwingenberg, Hesse, GermanyUSD 5.38 M––
Sustainable bio-based chemicals are manufactured using a proprietary platform.
2016Houston, Texas, United StatesUSD 686.05 M––
Biological insecticides and pesticides are developed from spider peptides.
2001Kalamazoo, Michigan, United StatesUSD 286.68 M––
Nitrogen-fixing microbes for corn crop nutrition are developed and applied.
2010Berkeley, California, United StatesUSD 618.08 M––
Instruments and software for color calibration are developed by Datacolor.
1970Lawrenceville, United States–USD 781.59 K20
Green acids are produced from microbes via synthetic biology.
2010Emeryville, California, United StatesUSD 51.77 M––
Phytochemicals are developed using microbial fermentation processes.
2011Cambridge, Massachusetts, United StatesUSD 115.93 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Holiferm

Holiferm was founded in 2018 and raised its 1st funding round 2 years after it was founded.

Holiferm is headquartered in Manchester, United Kingdom. It is registered at Manchester, Greater Manchester, United Kingdom.

Charles Dimmler is the current CEO of Holiferm.

Holiferm is a funded company, having raised a total of $25.73M across 4 funding rounds to date. The company's 1st funding round was a Grant of $474.91K, raised on Nov 2020.

Holiferm has 29 employees.

Manufacturer of biosurfactants. It uses renewable feedstocks and yeast-based fermentation processes to develop sophorolipid-based high and low foaming surfactants. Its biodegradable surfactants have applications in industrial and consumer products.

Holiferm's top competitors include Dispersa, Sironix and AGAE Technologies.

Holiferm offers Sophorolipid Products, GranuSurf, and LF Biosurfactants.

Holiferm operates through Holiferm Limited.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available